Lung Cancer Clinical Trials in Mexico City, Mexico City
2 recruitingMexico City, Mexico City, Mexico
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Study to Assess the Efficacy and Safety of Zipalertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB-IIIA NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection
Lung CancerEGFRNSCLC, Stage IB-IIIA+5 more
Taiho Oncology, Inc.360 enrolled214 locationsNCT07128199
Recruiting
Scale of Therapeutic Adherence to Respiratory Rahabilitation for Lung Cancer
Lung Cancer
Instituto Nacional de Cancerologia de Mexico281 enrolled1 locationNCT06477302